Language selection

Search

Details for: SANDOZ RISPERIDONE

Company: SANDOZ CANADA INCORPORATED

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02303655SANDOZ RISPERIDONERISPERIDONE0.25 MGTABLETORAL
02303663SANDOZ RISPERIDONERISPERIDONE0.5 MGTABLETORAL
02279800SANDOZ RISPERIDONERISPERIDONE1.0 MGTABLETORAL
02279819SANDOZ RISPERIDONERISPERIDONE2.0 MGTABLETORAL
02279827SANDOZ RISPERIDONERISPERIDONE3.0 MGTABLETORAL
02279835SANDOZ RISPERIDONERISPERIDONE4.0 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: